Riskpilot← Back to searchSign inGet full accessInflanova AB
ABActiveOrg 5565822292Karlbergsvägen 40 Lgh 1401Photographic activities · NACE 7420Est. 20000 employees
Revenue 2025
SEK 0
EBITDA margin
—
-30% vs 2024
Equity ratio
89.4%
Financial strength
Net profit 2025
SEK -114K
-30% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -114K | -30% |
| Net profit | SEK -114K | -30% |
| Total assets | SEK 170K | -15% |
| Equity | SEK 152K | +4% |
| Employees | 0 | — |
Legal name
Inflanova AB
Org number
5565822292
Legal form
Aktiebolag
NACE code
7420 · Photographic activities
Founded
19 januari 2000
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva utveckling inom medicin och immunologi
Address
Karlbergsvägen 40 Lgh 1401
Phone
+4686503323
Email
johan.frostegard@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 435 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 185 | −5 | −11 | −88 | −114 |
| Depreciation & amort. | −3 | −0 | −0 | −0 | −0 |
| EBIT | 182 | −5 | −11 | −88 | −114 |
| Net financials | — | — | — | — | — |
| Profit before tax | 182 | −5 | −11 | −88 | −114 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 182 | −5 | −11 | −88 | −114 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 204 | 100 | 101 | 200 | 170 |
| Equity | 120 | 95 | 84 | 146 | 152 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 84 | 5 | 17 | 54 | 18 |
| Total debt | 84 | 5 | 17 | 54 | 18 |
EBITDA margin
-11400000.0%
This company
15.8%
Market median
-72151999% vs market
20212025
Equity ratio
89.4%
This company
38.2%
Market median
+134% vs market
20212025
Return on equity
-75.0%
This company
18.4%
Market median
-508% vs market
20212025
Net profit margin
-11400000.0%
This company
8.1%
Market median
-140740841% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2023 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Inflanova AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Shailesh Kumar Samal | Chief Executive Officer | 0 companies |
| Erik Johan Frostegård | Chairman | 0 companies |
| Suar Mrutyunjay | Board of Directors | 0 companies |
| Lena Maria Evers | Board of Directors | 0 companies |
| Prem Sanker Satpathy | Board of Directors | 0 companies |
| Kent Anders Eriksson | Deputy Board Member | 0 companies |
| Anna Frostegård | Deputy Board Member | 0 companies |
| Sandeep Keshavan | Board of Directors | 0 companies |